6620 fundamentals
An in-depth look to HANDA PHARMACEUTICALS INC operating, investing, and financing activities
6620 free cash flow for Q2 24 is 4.22 M TWD. For 2023, 6620 free cash flow was 667.42 M TWD and operating cash flow was 668.36 M TWD.
Q1 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: TWD
Q1 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM